REGN - REGENERON PHARMACEUTICALS, INC.


766.66
-24.150   -3.150%

Share volume: 636,991
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.15%

PREVIOUS CLOSE
CHG
CHG%

$790.81
-24.15
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-02-2024 08-01-2024 10-31-2024 02-05-2025 04-29-2025 08-01-2025 10-28-2025 02-04-2026
Cash flow financing 47.100 M -478.100 M -634.000 M -1.136 B -1.089 B -1.128 B -717.900 M -780.100 M
Other financing cash flows 0.000 0.000 -120.200 M -253.400 M -4.300 M -5.600 M -3.000 M -519.200 M
Cash flow 1.513 B 354.000 M 82.800 M 477.900 M 603.400 M -1.078 B 497.900 M 610.900 M
Net income 722.000 M 1.432 B 1.341 B 917.700 M 808.700 M 1.392 B 1.460 B 844.600 M
Depreciation 114.100 M 120.700 M 121.700 M 126.400 M 126.900 M 135.100 M 136.700 M 145.000 M
Changes in inventories 2.715 B 2.874 B 0.000 0.000 152.300 M 0.000 0.000 0.000
Changes in receivables 5.222 B 5.717 B 0.000 0.000 0.000 0.000 0.000 0.000
Investing Cashflow -1.687 B -557.200 M -574.400 M 350.600 M 647.500 M -1.094 B -402.900 M 220.300 M
Net Borrowings -8.231 B -7.787 B 0.000 0.000 0.000 0.000 0.000 0.000
Investing Activity Other 0.000 0.000 0.000 -67.400 M -42.200 M -187.800 M -43.300 M -42.000 M
Dividends Paid 0.000 0.000 0.000 0.000 -93.800 M -92.600 M -91.200 M -92.700 M
Exchange Rate Effect 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Capital Expenditures -133.900 M -180.500 M 241.900 M 199.600 M 229.300 M 219.000 M 201.400 M 248.700 M
Cash Change 10.520 B 9.809 B 83.600 M 477.200 M 604.000 M -1.077 B 497.500 M 610.600 M